fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Nystatin

All products: general benefit

Ratio-Nystatin · DIN 02194228 · 100000U/g · Oint

General benefit; Health Canada lists this DIN as Cancelled post market since 2021-07-30 — choose a marketed DIN from the same-category list.Discontinued July 30, 2021 · checked October 5, 2026
StatusGeneral benefit; Health Canada lists this DIN as Cancelled post market since 2021-07-30 — choose a marketed DIN from the same-category list.
Write on scriptno code needed; Health Canada lists this DIN as Cancelled post market since 2021-07-30 — choose a marketed DIN from the same-category list.
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Ratio-Nystatin · DIN 02194228 Manufacturer: Ratiopharm Inc.; listing date 1997-10-31 Health Canada: Cancelled post market since 2021-07-30 · brand RATIO-NYSTATIN · ATC D01AA01 NYSTATIN · form Ointment · route Topical · ingredients NYSTATIN 100000 UNIT/G · company Teva canada limited · schedule Non-prescription drugs
Re-check Health Canada status and shortages (live) · Health Canada product record

Ratio-Nystatin: Formulary list price $0.13 per unit (the source does not state the unit; exact figure $0.1277). What the ministry pays, not the patient.

Ministry pays: $0.1277 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02194228)

Source record
DIN 02194228: Ratio-Nystatin Raw flags: sec3=Y Item: 840408005; group id 823; item number 2006; lccId None; manufacturer id RPH Source form: Oint; strength: 100000U/g Recorded listing: General benefit Source prices (unrounded): $0.1277; ministry $0.1277 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02194228 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=35799 Therapeutic Notes (formulary) Nystatin is not effective in the treatment of Dermatophyte infections or Tinea versicolor.
Interchangeable products
Mycostatin · DIN 00029556 · not recorded
Shortage status: resolved shortage (ended July 10, 2017); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02194228
Shortage record checked October 6, 2026
Health Canada lists this DIN as Cancelled post market since July 30, 2021 — choose a marketed DIN from the same-category list.

Other products in the same Health Canada class (D01A): coverage varies; not interchangeable

  • Clotrimazole (Clotrimaderm): general benefit, not a benefit
  • Ketoconazole (Nizoral): general benefit, not a benefit
  • Miconazole nitrate (Micatin): general benefit
  • Terbinafine (Lamisil): general benefit
  • Ciclopirox (Penlac): not a benefit
  • Betamethasone dipropionate + clotrimazole (Lotriderm Cream): not a benefit
Other drugs in the same formulary class (84:04:08 Fungicides) and how they are covered

Matched class: 84:04:08 Fungicides

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: MICONAZOLE NITRATE, TERBINAFINE HCL Some products covered without a code (check the product listing): CLOTRIMAZOLE, KETOCONAZOLE, TERCONAZOLE 84:04:08 Fungicides

CLOTRIMAZOLE

· 7 products · General benefit (6), Listed, not a benefit (1) · strengths: 10mg/g, 500mg & 1%, 20mg/g · Cr, Tab & Cr, Vag Cr-App

KETOCONAZOLE

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 2% · Cr

MICONAZOLE NITRATE

· 1 products · General benefit · strengths: 2% · Cr

TERBINAFINE HCL

· 1 products · General benefit · strengths: 1% · Cr

CICLOPIROX

· 3 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 8% W/W · Top Sol

CLOTRIMAZOLE & BETAMETHASONE DIPROPIONATE

· 2 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 1% w/w & 0.05% w/w · Top Cr

TERCONAZOLE

· 2 products · Listed, not a benefit (1), General benefit (1) · strengths: 0.4% · Vag Cr

FLUCONAZOLE

· 9 products · Limited Use, codes 235 · strengths: 150mg · Cap Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 84:04:08
Full class listing Related classes: 84:04:04 Antibiotics, 84:04:12 Parasiticides, 84:04:16 Other Anti-Infectives Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
Product monograph unavailable: no link